Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review
Aims: There are limited therapeutic options for drug-induced liver injury (DILI). N-acetylcysteine (NAC ) is known to be of benefit in management of DILI due to paracetamol overdose and may also be useful in the management of non-paracetamol DILI. Our objective was to systematically review evidence...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Clinical Pharmacology
2016
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: N-Acetylcysteine for non-paracetamol drug-induced liver injury: A systemic review
- Liver Injury in HIV-positive Patients on Antituberculosis and/or Antiretroviral Therapy – Assessing Causality
- The clinical role of therapeutic drug monitoring of antiretrovirals : a Cochrane systematic review
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Population pharmacokinetics and pharmacokinetic-pharmacodyamic modeling of antitubercular drugs
- Determination of total, unbound, and intracellular concentrations of the antiretroviral drugs Efavirenz, Lopinavir, and Ritonavir